Smoore's 2025 first-half performance: Revenue rose 18.3% to 6.013 billion yuan, with self - brand revenue up 14.1% to 1.274 billion yuan

Aug.21.2025
Smoore's 2025 first-half performance: Revenue rose 18.3% to 6.013 billion yuan, with self - brand revenue up 14.1% to 1.274 billion yuan
In the first half of 2025, Smoore's revenue reached 6.013 billion yuan, up by 18.3%. The adjusted net profit was 737 million yuan, down by 2.1%. The ToB business revenue was 4.739 billion yuan, up by 19.5%, while the self - brand business revenue was 1.274 billion yuan, up by 14.1%.

Key points:

 

·Overall performance:

Total revenue was 6.013 billion yuan, an increase of 18.3% year-on-year. Net profit for the period was 492 million yuan, a decrease of 28% year-on-year. Adjusted net profit was 737 million yuan, a slight decrease of 2.1% year-on-year.

 

·Performance of business segments:

Total revenue from ToB business reached 4.739 billion RMB, a year-on-year increase of 19.5%. Revenue from proprietary brand businesses amounted to 1.274 billion RMB, representing a 14.1% increase compared to the previous year.

 

·Regional market performance:

Europe and other countries: Revenue of RMB 2.734 billion, a year-on-year increase of 38%. U.S. market: Revenue of RMB 1.888 billion, a year-on-year increase of 1.5%. Mainland China: Revenue of RMB 0.117 billion, a year-on-year decrease of 6.1%.

 

·New business highlights:

HNB products: Support strategic clients to launch high-end series in the Japanese market and plan nationwide promotion in September. Special purpose atomization and medical, beauty business: Revenue of Lanmei beauty device reached 31 million RMB, a year-on-year increase of 2595%.

 

·Research and Development investment:

Research and development expenditures: 723 million RMB, a decrease of 4.9% year-on-year. Future direction: Focus on HNB and atomized medical sector.

 


 

According to a message from Smoore's official website on August 20th, Smoore International (06969.HK) announced its performance for the first half of 2025: the group achieved revenue of approximately RMB 6.013 billion, an 18.3% increase year-on-year; net profit for the period was approximately RMB 492 million, a 28% decrease year-on-year; excluding non-cash expenses such as share-based payments, adjusted net profit was approximately RMB 737 million, a slight decrease of 2.1% year-on-year.

 

Among them, the revenue of ToB business reached 4.739 billion yuan, a year-on-year increase of 19.5%, mainly driven by the increasing demand for compliant products following the European market's ban on disposable electronic cigarettes. The revenue of the self-owned brand business reached approximately 1.274 billion yuan, representing a year-on-year increase of 14.1%.

 

By region, revenue (ToB) in Europe and other countries increased by 38% year-on-year to 27.34 billion yuan, revenue (ToB) in the US market was approximately 18.88 billion yuan, a year-on-year growth of 1.5%, and revenue (ToB) in mainland China decreased by about 6.1% year-on-year to 1.17 billion yuan.

 

Smoore stated that in the HNB (Heat-Not-Burn) product field, the group has supported strategic clients in launching high-end series in the Japanese market and plans to promote nationwide in September; the special purpose atomization and medical, beauty business continue to advance, with the revenue of the Lan Zhi beauty instrument reaching 310 million yuan, a year-on-year increase of 2595%.

 

In addition, Smoore's research and development expenses were 723 million yuan, a decrease of 4.9% from the previous year, with a focus on HNB and atomization medical directions in the future.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

UK Parliament Briefing Puts Vape Hardware Design and Materials in Regulatory Focus
UK Parliament Briefing Puts Vape Hardware Design and Materials in Regulatory Focus
The UK Parliament’s Parliamentary Office of Science and Technology (POST) has published a scientific briefing reviewing current evidence on the health effects of vape device components, including heating elements, power settings, metals, plastics, batteries and e-liquid ingredients, signalling growing regulatory attention to device design and whole-product systems beyond e-liquids, flavours and packaging.
Special Report
Jun.29
Reuters: Shopify May Ban All Vape Sales This Week Amid Illegal Market Crackdown
Reuters: Shopify May Ban All Vape Sales This Week Amid Illegal Market Crackdown
Reuters reported that Shopify may ban all vape products from its platform as soon as this week, signaling that U.S. enforcement against the illegal vape market is expanding from retailers and importers to e-commerce platforms and payment networks.
MarketBAT
Jun.23 by 2Firsts Perspectives
AP Questions FDA Rationale as Glas Fruit-Flavored Vapes Won Authorization Without Added Cessation Benefit
AP Questions FDA Rationale as Glas Fruit-Flavored Vapes Won Authorization Without Added Cessation Benefit
The U.S. Food and Drug Administration (FDA) recently authorized two fruit-flavored vaping products from Glas, but a newly released agency memo shows the products did not demonstrate greater smoking-cessation benefits than tobacco-flavored e-cigarettes. The Associated Press said the findings are likely to raise further questions about the FDA’s regulatory rationale and standards for flavored vaping products.
Jun.12
U.S. Convenience Stores Rebalance Backbar as Nicotine Pouches Outpace Cigarettes
U.S. Convenience Stores Rebalance Backbar as Nicotine Pouches Outpace Cigarettes
As cigarette volumes continue to decline, U.S. convenience-store operators are reconfiguring backbar space to accommodate modern oral nicotine products such as nicotine pouches. Industry data show nicotine pouches have become one of the fastest-growing nicotine categories while generating higher margins for retailers.
Jun.12
Product | JT Upgrades with2 Infused Tobacco Capsules With Double-Size BIG PACK
Product | JT Upgrades with2 Infused Tobacco Capsules With Double-Size BIG PACK
Japan Tobacco Inc. (JT) announced that it will introduce a BIG PACK version of all five tobacco capsule variants designed for its with2 infused tobacco system. Scheduled for release in Japan on August 4, 2026, the refreshed packaging doubles the contents from five capsules and one cartridge to ten capsules and two cartridges while maintaining the same flavors and formulations
News
Jun.26 by 2Firsts Perspectives
Italy Fines PMI €7 Million Over Misleading ‘Smoke-Free Future’ Marketing Claims
Italy Fines PMI €7 Million Over Misleading ‘Smoke-Free Future’ Marketing Claims
Italy’s Competition and Market Authority (AGCM) has fined Philip Morris Italia €7 million, finding that the company’s use of “smoke-free future” and related claims in promoting products such as IQOS, VEEV and ZYN could mislead consumers.
Jun.16